[1]Tsai TT, Patel UD, Chang TI, et al.Contemporary incidence,predictors,and outcomes of acute kidney injury in patients undergoing percutaneous coronary inter-ventions: insights from the NCDR Cath-PCI registry[J].JACC Cardiovasc Interv, 2014, 7(1):1-9
[2]Stratta P, Quaglia M, Airoldi A, Aime S.Structure-function relationships of iodinated contrast media and risk of nephrotoxicity[J].Curr Med Chem, 2012, 19(5):736-743
[3]中华医学会放射学分会对比剂安全使用工作组.碘对比剂使用指南第版[J].中华放射学杂志, 2013, 47(10):869-872
[4]Mehran R, Nikolsky E, Kirtane AJ, et al.Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study[J].JACC Cardiovasc Interv, 2009, 2(5):415-421
[5]Isaka Y, Hayashi H, Aonuma K, et al; Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group.Guideline on the use of iodinated contrast media in patients with kidney disease 2018[J].Jpn J Radiol, 2020, 38(1):3-46
[6]Mehran R, Aymong ED, Nikolsky E, et al.A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation[J].J Am Coll Cardiol, 2004, 44(7):1393-1399
[7]Maioli M, Toso A, Gallopin M, et al.Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention[J].J Cardiovasc Med (Hagerstown), 2010, 11(6):444-449
[8]Termorshuizen F, Dekker FW, van Manen JG, et al.Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2[J].J Am Soc Nephrol, 2004, 15(4):1061-1070
[9]Vilar E, Wellsted D, Chandna SM, et al.Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose[J].Nephrol Dial Transplant, 2009, 24(8):2502-2510
[10]Shafi T, Jaar BG, Plantinga LC, et al.Association of residual urine output with mortality,quality of life,and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study[J].Am J Kidney Dis, 2010, 56(2):348-358
[11]Wong PC, Li Z, Guo J, et al.Pathophysiology of contrast-induced nephropathy[J].Int J Cardiol, 2012, 158(2):186-192
[12]Rocco M, Soucie JM, Pastan S, et al.Peritoneal dialysis adequacy and risk of death[J].Kidney Int, 2000, 58(1):446-457
[13]Bargman JM, Thorpe KE, Churchill DN，CANUSA Peritoneal Dialysis Study Group.Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study[J].J Am Soc Nephrol, 2001, 12(10):2158-2162
[14]Liao CT, Chen YM, Shiao CC, et al.Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis[J].Nephrol Dial Transplant, 2009, 24(9):2909-2914
[15]Marrón B.Benefits of preserving residual renal function in peritoneal dialysis[J]. Kidney Int Suppl,2008（108）:S42-51.
[16]Haag-Weber M.The impact of residual renal function on survival[J].Nephrol Dial Transplant, 2008, 23(7):2123-2126
[17]Chen CH, Perl J, Teitelbaum I.Prescribing high-quality peritoneal dialysis: The role of preserving residual kidney function[J]. Perit Dial Int, 2020 May; 40(3):274-281.
[18]Singhal MK, Bhaskaran S, Vidgen E, et al.Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it[J].Perit Dial Int, 2000, 20(4):429-438
[19]National Kidney Foundation.KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update[J].Am J Kidney Dis, 2015, 66(5):884-930
[20]Locatelli F, Aljama P, Bárány P, et al; European Best Practice Guidelines Working Group.Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure[J]. Nephrol Dial Transplant, 2004, 19 Suppl 2:ii1-47.
[21]Mehran R, Dangas GD, Weisbord SD.Contrast-Associated Acute Kidney Injury[J].N Engl J Med, 2019, 380(22):2146-2155
[22]Persson PB, Hansell P, Liss P.Pathophysiology of contrast medium-induced nephropathy[J].Kidney Int, 2005, 68(1):14-22
[23]Janousek R, Krajina A, Peregrin JH, et al.Effect of intravascular iodinated contrast media on natural course of end-stage renal disease progression in hemodialysis patients: a prospective study[J].Cardiovasc Intervent Radiol, 2010, 33(1):61-66
[24]Swan SK, Halstenson CE, Kasiske BL, et al.Determination of residual renal function with iohexol clearance in hemodialysis patients[J].Kidney Int, 1996, 49(1):232-235
[25]Oloko A, Talreja H, Davis A, et al.Does Iodinated Contrast Affect Residual Renal Function in Dialysis Patients? A Systematic Review and Meta-Analysis[J].Nephron, 2020, 144(4):176-184
[26]Dittrich E, Puttinger H, Schillinger M, et al.Effect of radio contrast media on residual renal function in peritoneal dialysis patients–a prospective study[J].Nephrol Dial Transplant, 2006, 21(5):1334-1339
[27]Moranne O, Willoteaux S, Pagniez D, et al.Effect of iodinated contrast agents on residual renal function in PD patients[J].Nephrol Dial Transplant, 2006, 21(4):1040-1045
[28]Weisbord SD, Bernardini J, Mor MK, et al.The effect of coronary angiography on residual renal function in patients on peritoneal dialysis[J]. Clin Cardiol, 2006, 29:494–497.
[29]Faucon A L, Bobrie G, Clément O, et al.Nephrotoxicity of iodinated contrast media: From pathophysiology to prevention strategies[J].Eur J Radiol, 2019, 116:231-241.
[30]Weisbord SD, Gallagher M, Jneid H, et al; PRESERVE Trial Group.Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine[J].N Engl J Med, 2018, 378(7):603-614
[31]Boccalandro F, Shreyder K, Harmon L，et al.Five-Year Follow-Up of Patients With Radio-Contrast-Induced Acute Renal Injury: Can Intravenous Sodium Bicarbonate Improve Long-Term Outcomes? [J]Cardiovasc Revasc Med, 2021, 31:61-68.
[32]Davenport MS, Perazella MA, Yee J, et al.Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation[J].Radiology, 2020, 294(3):660-668
[33]Van der Molen AJ, Reimer P, Dekkers IA, et al .Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines[R]. Eur Radiol，2018，28(7):2856-2869.
[34]Subramaniam RM, Suarez-Cuervo C, Wilson RF, et al.Effectiveness of prevention strategies for contrast-induced nephropathy:a systematic review and meta-analysis[J].Ann Intern Med, 2016, 164(6):406-441
[35]Iwamoto M, Hiroshige K, Suda T, et al.Elimination of iomeprol in patients undergoing continuous ambulatory peritoneal dialysis[J]. Perit Dial Int,1999,19:380–385.
[36]Herget-Rosenthal S, von Ostrowski M, Kribben A.Definition and risk factors of rapidly declining residual renal function in peritoneal dialysis: an observational study[J]. Kidney Blood Press Res, 2012, 35:233–241.
[37]Kim IY, Lee SB, Lee DW, Song SH, et al.Long-term effect of radiocontrastenhanced computed tomography on the renal function of chronic kidney disease patients[J].Clin Exp Nephrol, 2012(16):755–759.
[38]Hassan K, Fadi H.Is hypoalbuminemia aprognostic risk factor for contrast-induced nephropathy in peritoneal dialysis patients
[39]吴华, 孙福成, 毛永辉, 等.血液透析患者与心脏介入性诊断治疗[J].中国血液净化, 2002, 1(11):10-13
[40]宋岩, 李冀军, 黄党生, 等.球囊扩张及支架在慢性透析患者冠心病治疗中的应用及疗效分析[J].中国血液净化, 2005, 4(11):588-591
